NeOnc to release NEO100 Phase 2a trial data on August 12

August 10, 2026 10:34 AM

NeOnc Technologies (NASDAQ: NTHI) is scheduled to release topline Phase 2a results for its investigational drug NEO100 on August 12 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found